Comments about the editorial by Bénédicte Mugnier and Jean Roudier entitled "Factors predicting responsiveness to anti-TNFα therapy in patients with rheumatoid arthritis: Using biotherapies rationally" [5] (multiple letters)

Joint Bone Spine

Volumn 72, Issue 4, 2005, Pages 346-347

  Lequerré, Thierry ^a   Vittecoq, Olivier ^a   Le Loët, Xavier ^a   Mugnier, Bénédicte ^b   Roudier, Jean ^b  

^a Dept de Médecine Interne Ctr Hosp Univ Rouen Boisguillaume   (France)

^b NONE

Author keywords

Anti TNF; Rheumatoid arthritis

Indexed keywords

ETANERCEPT; INFLIXIMAB; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

BIOINFORMATICS; CLINICAL PRACTICE; DNA MICROARRAY; DRUG RESPONSE; GENE EXPRESSION; GENETIC ALGORITHM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC TRAIT; GENOTYPE; HUMAN; LETTER; MARKER GENE; PREDICTION; RHEUMATOID ARTHRITIS; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

EID: 22244477366     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2005.01.004     Document Type: Letter

References (8)

1. B. Mugnier J. Roudier Factors predicting responsiveness to anti-TNFalpha therapy in patients with rheumatoid arthritis: using biotherapies rationally Joint Bone Spine 71 2004 91 94
2. J.A. Pinto A. Mosquera J.L. Fernandez-Garcia M. Freire F.J. De Toro E. Maneiro Polymorphism in the TNF promotergene (–308Å) correlates with worse response to infliximab in rheumatoid arthritis Ann Rheum Dis 63 Suppl 1 2003 183 [Abstract]
3. H.T. Ang S. Helfgott Do the clinical responses and complications following etanercept or infliximab therapy predict similar outcomes with the other tumor necrosis factor-alpha antagonists in patients with rheumatoid arthritis? J Rheumatol 30 2003 2315 2318
4. S. Louis Bridges Jr Genetic markers of treatment response in rheumatoid arthritis Arthritis Rheum 50 2004 1019 1022
5. T. Lequerré A.C. Jauneau G. Lefebvre O.V. Vittecoq S. Pouplin M. Daveau Gene expression profiling in PBMCs as a tool for prediction of infliximab responsiveness in rheumatoid arthritis. ACR 2004, San Antonio Arthritis Rheum 2004 S398 [Abstract 982]
6. S.P. Bohen O.G. Troyanskaya O. Alter R. Warnke D. Botstein P.O. Brown Variation in gene expression patterns in follicular lymphoma and the response to rituximab Proc Natl Acad Sci USA 100 2003 1926 1930
7. C. Trocmé H. Marotte L. Grange P. Colin-Morel B. Prades C. Alexandre Serum biomarkers of predictive response to rheumatoid arthritis infliximab treatment: proteinchip technology Ann Rheum Dis 63 Suppl 1 2003 293 [Abstract FRI0147]
8. C. Trocmé L. Grange H. Marotte B. Prades C. Alexandre J. Tebib Predictive response to rheumatoid arthritis infliximab treatment: detection of serum biomarkers by SELDI-TOF technology. ACR 2004, San Antonio Arthritis Rheum 2004 S244 [Abstract 535]